Diagnostic Microchip Inserted Under Skin Can Detect COVID-19
By LabMedica International staff writers Posted on 14 Apr 2021 |
Image: Diagnostic Microchip Inserted Under Skin Can Detect COVID-19 (Photo courtesy of DARPA)
Researchers have created a microchip that can detect COVID-19 when inserted under the skin.
The implantable microchip developed by medical researchers at the US Pentagon’s Defense Advanced Research Projects Agency (DARPA; Arlington, VA, USA) can monitor the human body for signs of the SARS-CoV-2 virus. Details of the revolutionary technology were shared on the 60 Minutes Show by Matthew Hepburn, an infectious disease physician and retired Army colonel who is heading DARPA’s response to the pandemic.
Hepburn told CBS that the microchip, embedded in a tissue-like gel, would continuously test the chip recipient’s blood for presence of the coronavirus. Upon detecting COVID-19, the chip would alert the patient to conduct a self-administered rapid blood test to confirm the positive result. According to Hepburn, DARPA had also developed a filter to remove the SARS-CoV-2 virus from the blood through a dialysis machine. The filter had been approved by the US Food and Drug Administration (FDA) and had already been used on 300 patients. Additionally, Hepburn compared the diagnostic microchip to a car’s “Check engine” alert and assured that DARPA’s chip would neither “track your every move” nor be administered via vaccines.
“It’s a sensor,” Hepburn told CBS. “That tiny green thing in there, you put it underneath your skin and what that tells you is that there are chemical reactions going on inside the body and that signal means you are going to have symptoms tomorrow. We can have that information in three to five minutes. As you truncate that time, as you diagnose and treat, what you do is you stop the infection in its tracks.”
Related Links:
Defense Advanced Research Projects Agency (DARPA)
The implantable microchip developed by medical researchers at the US Pentagon’s Defense Advanced Research Projects Agency (DARPA; Arlington, VA, USA) can monitor the human body for signs of the SARS-CoV-2 virus. Details of the revolutionary technology were shared on the 60 Minutes Show by Matthew Hepburn, an infectious disease physician and retired Army colonel who is heading DARPA’s response to the pandemic.
Hepburn told CBS that the microchip, embedded in a tissue-like gel, would continuously test the chip recipient’s blood for presence of the coronavirus. Upon detecting COVID-19, the chip would alert the patient to conduct a self-administered rapid blood test to confirm the positive result. According to Hepburn, DARPA had also developed a filter to remove the SARS-CoV-2 virus from the blood through a dialysis machine. The filter had been approved by the US Food and Drug Administration (FDA) and had already been used on 300 patients. Additionally, Hepburn compared the diagnostic microchip to a car’s “Check engine” alert and assured that DARPA’s chip would neither “track your every move” nor be administered via vaccines.
“It’s a sensor,” Hepburn told CBS. “That tiny green thing in there, you put it underneath your skin and what that tells you is that there are chemical reactions going on inside the body and that signal means you are going to have symptoms tomorrow. We can have that information in three to five minutes. As you truncate that time, as you diagnose and treat, what you do is you stop the infection in its tracks.”
Related Links:
Defense Advanced Research Projects Agency (DARPA)
Latest COVID-19 News
- New Immunosensor Paves Way to Rapid POC Testing for COVID-19 and Emerging Infectious Diseases
- Long COVID Etiologies Found in Acute Infection Blood Samples
- Novel Device Detects COVID-19 Antibodies in Five Minutes
- CRISPR-Powered COVID-19 Test Detects SARS-CoV-2 in 30 Minutes Using Gene Scissors
- Gut Microbiome Dysbiosis Linked to COVID-19
- Novel SARS CoV-2 Rapid Antigen Test Validated for Diagnostic Accuracy
- New COVID + Flu + R.S.V. Test to Help Prepare for `Tripledemic`
- AI Takes Guesswork Out Of Lateral Flow Testing
- Fastest Ever SARS-CoV-2 Antigen Test Designed for Non-Invasive COVID-19 Testing in Any Setting
- Rapid Antigen Tests Detect Omicron, Delta SARS-CoV-2 Variants
- Health Care Professionals Showed Increased Interest in POC Technologies During Pandemic, Finds Study
- Set Up Reserve Lab Capacity Now for Faster Response to Next Pandemic, Say Researchers
- Blood Test Performed During Initial Infection Predicts Long COVID Risk
- Low-Cost COVID-19 Testing Platform Combines Sensitivity of PCR and Speed of Antigen Tests
- Finger-Prick Blood Test Identifies Immunity to COVID-19
- Quick Test Kit Determines Immunity Against COVID-19 and Its Variants